EUVIMEDEUVIMED entdecken
Crossref

Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy

Jae-Won Park, Kyung-Oh Doh, Sungjin Jeon iD, Kwang Seok Kim, Jong-Ik Heo, Jong-Soo Choi iD

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.6c00038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Jae-Won Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea. Hauptthemen laut MEDLINE: Doxorubicin, Radiation-Sensitizing Agents, Sitosterols, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Engineering Research Centers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinRadiation-Sensitizing AgentsSitosterolsBiocompatible MaterialsAntineoplastic AgentsAnimalsHumansMiceCell ProliferationMaterials TestingDrug Screening Assays, AntitumorParticle SizeApoptosisCell SurvivalMolecular StructureFemaleDose-Response Relationship, Drug

Stichwörter der Autor:innen

chemoradiotherapydoxorubicin conjugatenanoparticleradiosensitizerβ-sitosterol

Substanzen

DoxorubicinRadiation-Sensitizing AgentsSitosterolsBiocompatible Materialsgamma-sitosterolAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.
  • Department of Chemistry, College of Natural Sciences, The University of Texas at Austin, Austin, Texas 78712, United States.
  • Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.

ORCID-Profile: Sungjin Jeon, Jong-Soo Choi

Förderung

  • Engineering Research Centers

Zitieren

APA

Park, J. W., Doh, K. O., Jeon, S., Kim, K. S., Heo, J. I., & Choi, J. S. (2026). Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00038

Vancouver

Park JW, Doh KO, Jeon S, Kim KS, Heo JI, Choi JS. Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00038

BibTeX
@article{Park2026,
  author = {Park, Jae-Won and Doh, Kyung-Oh and Jeon, Sungjin and Kim, Kwang Seok and Heo, Jong-Ik and Choi, Jong-Soo},
  title = {Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00038}
}
Kostenlos starten →